
In the breast, cancer stem cells and normal stem cells can arise from different cell types and tap into distinct yet related stem cell programs, according to researchers. The differences between these stem cell programs may be significant enough to be exploited by future therapeutics.
http://www.sciencedaily.com/releases/2015/09/150903121944.htm